Moxonidin Actavis (Moxonidine)

Moxonidine, the active ingredient in Moxonidin Actavis, is an imidazoline receptor agonist presented as a tablet for oral use. It is employed to lower elevated blood pressure in adults with hypertension. GNH USA supplies Moxonidin Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxonidine is indicated for the management of hypertension, acting on central sympathetic pathways to reduce blood pressure.

- Essential hypertension: helps achieve target blood‑pressure goals in patients with primary hypertension. - Resistant hypertension: provides additional blood‑pressure control when other agents are insufficient. - Elevated systolic blood pressure: lowers systolic readings in adults with high systolic values.

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dry mouth: sensation of oral dryness. - Fatigue: feeling of tiredness or lack of energy. - Dizziness: light‑headedness, especially when standing quickly. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Bradycardia: unusually slow heart rate. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Liver enzyme elevation: abnormal liver function tests. - Depression: new or worsening mood symptoms. - Cardiac arrhythmia: irregular heart rhythm.

Before initiating therapy, consider the following safety measures.

- Blood pressure monitoring: check BP regularly to assess response and avoid excessive lowering. - Renal impairment: adjust dose or monitor closely in patients with reduced kidney function. - Diabetes mellitus: watch for changes in glucose control as sympathetic tone influences insulin sensitivity. - Abrupt discontinuation: taper the dose to prevent rebound hypertension. - Elderly patients: start at the lowest effective dose and monitor for dizziness. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Moxonidine can interact with other medicines that affect blood pressure or sympathetic activity.

Major Interactions (Avoid): - Other central antihypertensives (e.g., clonidine): additive hypotensive effect may cause severe low BP. - ACE inhibitors or ARBs combined with diuretics: risk of excessive blood‑pressure reduction.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive response. - Alcohol: can enhance dizziness and hypotension. - Lithium: possible increase in lithium levels; monitor serum concentrations.